Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves
Source abstract
Abstract
Abstract Glutaraldehyde‐fixed porcine aortic valve tissues are widely used for heart valve replacement surgery in the form of bioprosthetic heart valves (BHVs). The durability of BHVs in the clinical setting is limited by tissue degeneration, mechanical failure, and calcification. BHVs rely on the putative ability of glutaraldehyde to render biologic tissues metabolically inert and fully resistant to enzymatic attack. In the present study, we detected and partially characterized the activity of collagen and elastin‐degrading enzymes in unimplanted, glutaraldehyde‐fixed porcine aortic cusp and wall tissues and compared enzyme activities with those extracted from fresh tissues. Active enzymes capable of degrading extracellular matrix were found to be present in soluble form as well as immobilized on glutaraldehyde‐crosslinked tissue matrix. Total levels of collagenolytic activities were evaluated to approximately 0.25 μg of degraded collagen/mg of dry tissue/24 h for both glutaraldehyde‐fixed wall and cusp tissues. A major finding of this study was the ability of soluble tissue enzymes to partially degrade glutaraldehyde‐fixed collagen and particularly large amounts of glutaraldehyde‐fixed elastin. These calcium‐dependent gelatinases share many biochemical similarities with matrix metalloproteinases. These data strongly indicate that glutaraldehyde‐fixed porcine valvular tissues are not metabolically inert and are not entirely resistant to enzymatic attack, thereby rendering BHVs vulnerable to biologic degeneration and subsequent chronic failure. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 66A: 755–763, 2003
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cardiac Valve Diseases and Treatments · Electrospun Nanofibers in Biomedical Applications · Cardiac and Coronary Surgery Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O ↗
2. 10.1161/hc4601.09948910.1161/hc4601.099489 ↗
3. 10.1111/j.1540-8191.1994.tb00932.x10.1111/j.1540-8191.1994.tb00932.x ↗
4. Prevention of glutaraldehyde‐fixed bioprosthetic heart valve calcification by alcohol pretreatment: Further mechanistic studies [In Process Citation]
5. 10.1002/(SICI)1097-4636(199907)46:1<44::AID-JBM5>3.0.CO;2-D10.1002/(SICI)1097-4636(199907)46:1<44::AID-JBM5>3.0.CO;2-D ↗
6. 10.1016/S0002-9440(10)64602-010.1016/S0002-9440(10)64602-0 ↗
7. 10.1163/156856297X0019110.1163/156856297X00191 ↗
8. The role of glutaraldehyde‐induced crosslinks in calcification of bovine pericardium used in cardiac valve bioprostheses
9. 10.1002/jbm.82027061510.1002/jbm.820270615 ↗
10. 10.1097/00002480-199609000-0004910.1097/00002480-199609000-00049 ↗
11. 10.1016/0003-2697(89)90101-210.1016/0003-2697(89)90101-2 ↗
12. 10.1016/0003-2697(84)90242-210.1016/0003-2697(84)90242-2 ↗
13. 10.1515/bchm2.1976.357.2.124510.1515/bchm2.1976.357.2.1245 ↗
14. 10.1016/0014-5793(89)81107-X10.1016/0014-5793(89)81107-X ↗
15. 10.1016/S0165-0270(97)00065-410.1016/S0165-0270(97)00065-4 ↗
16. 10.1177/15.11.65210.1177/15.11.652 ↗
17. Some aspects of fixation with glutaraldehyde. A biochemical and histochemical comparison of the effects of formaldehyde and glutaraldehyde fixation on various enzymes and glycogen, with a note on penetration of glutaraldehyde into liver
18. Phosphatase enzyme activity is retained in glutaraldehyde treated bioprosthetic heart valves
19. 10.1002/jbm.82021060610.1002/jbm.820210606 ↗
20. 10.1016/S0002-9440(10)65197-810.1016/S0002-9440(10)65197-8 ↗
21. 10.1016/S0958-1669(99)80059-710.1016/S0958-1669(99)80059-7 ↗
22. 10.1615/JLongTermEffMedImplants.v11.i34.9010.1615/JLongTermEffMedImplants.v11.i34.90 ↗
23. Morphology of porcine aortic valve cusp elastin
24. Biaxial strain properties of elastase‐digested porcine aortic valves
25. 10.3109/0300820980902890510.3109/03008209809028905 ↗
26. Comparative in‐vitro fluid dynamics characterization of heart valve bioprostheses under accelerated fatigue conditions and under physiologic conditions
27. 10.1016/S0142-9612(99)00013-710.1016/S0142-9612(99)00013-7 ↗